Apoptosis and p53 are associated with effect of preoperative radiation in oral squamous cell carcinomas

Cancer Letters

Volumn 154, Issue 1, 2000, Pages 71-77

  Shintani, Satoru ^a   Mihara, Mariko ^a   Nakahara, Yuuji ^a   Terakado, Nagaaki ^a   Yoshihama, Yasuto ^a   Kiyota, Akihisa ^a   Ueyama, Yoshiya ^a   Matsumura, Tomohiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Oral cancer; p53; Proliferating nuclear antigen; Radiosensitivity

Indexed keywords

PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH TUMOR; PATIENT SELECTION; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034213853     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00376-1     Document Type: Article

References (17)

1. Mariya Y., Fukuda E., Tarusawa N. An analysis of tumor cell kinetics, using the Ki-67 monoclonal antibody, and the correlation of these kinetics on the radiotherapeutic effect. Jpn. J. Cancer Clin. 37:1992;870-875.
2. Oka K., Hoshi T., Arai T. Prognostic significance of the PC10 index as a prospective assay for cervical cancer treated with radiation therapy alone. Cancer. 70:1992;1545-1550.
3. Clarhe A.R., Purdie C.A., Harrison D.J., Morris R.G., Bird C.C., Hopper M.L., Wyllie A.H. Thymocyte apoptosis induced by p53- dependent and independent pathways. Nature. 362:1993;849-852.
4. Garzetti G.G., Ciavattini A., Provinciali M., Distefano G., Lucarini G., Goteri G., Biagini G. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based preoperative chemotherapy. Anticancer Res. 1996;3229-3234.
5. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., Jacks T. p53 is required for radiation-induction apoptosis in mouse thymocyte. Nature. 362:1993;847-849.
6. Paradiso A., Rabinovich M., Vallejo C., Machiavelli M., Romero A., Perz J., Lacava J., Cuevas M.A., Rodriquez R., Leone B., Sapia M.G., Simone G., De Lena M. p53 and PCNA expression in advanced colorectal cancer: response to chemotherapy and long term prognosis. Int. J. Cancer. 69:1996;437-441.
7. Puglisi F., Di loreto D., Panizzo R., Avellini C., Fongione S., Cacitti V., Beltrami C.A. Expression of p53 and bcl-2 and response to preoperative chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the oesophagus. J. Clin. Pathol. 49:1996;456-459.
8. Shintani S., Yoshihama Y., Alcalde E.R., Matsumura T. Overexpression of p53 is an early in the tumorigenesis of oral squamous cell carcinomas. Anticancer Res. 15:1995;305-308.
9. Symonds H., Krall L., Remington L., Saenz Robles M., Lowe S., Jacks T., van Dyke T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell. 78:1994;703-711.
10. Sobin L.H., Wittekind Ch. TMN classification of malignant tumors. 5th Edition :1997;17-47 International Union Against Cancer, Genova, Switzerland.
11. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
12. Birchall M.A., Winterfold C.M., Allan D.J., Harmon B.V. Apoptosis in normal epithelium, premalignant and malignant lesions of the oropharynx and oral cavity: a preliminary study. Oral Oncol. 31:1995;380-383.
13. O'Connor P.M., Jackman J., Jondle D., Bathia K., Magrath I., Kohn K.W. Role of p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 51:1993;5171-5176.
14. Nabeya Y., Loganzo F., Maslak P., Lai L.D.E., Oliveira A.R., Schwatz G.K., Blundell M.L., Altorki N.K., Kelsen D.P., Albino A.P. The mutation status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents. Int. J. Cancer. 64:1995;37-46.
15. Tan L.K.S., Odgen G.R. overexpression in laryngeal carcinoma is not predictive of response to radiation. Oral Oncol. 33:1997;177-181.
16. Makris A., Powles T.J., Dowsett M., Allred C. protein overexpression and chemosensitivity in breast cancer. Lancet. 345:1995;1181-1182.
17. Harris C.C., Hollstein M. Clinical implication of p53 tumor suppressor gene. N. Engl. J. Med. 329:1993;1318-1327.